Home » Newsletters » BioWorld

BioWorld

Oct. 4, 1991

View Archived Issues

TRIALS BEGIN ON VIMRX AIDS DRUG

MID-ATLANTIC VENTURE FAIR HIGHLIGHTS

ONCOSCINT APPROVED IN GERMANY

MIXED SIGNALS ON CENTOXIN PROSPECTS

DNAP RAISES $28.4 MILLION IN STOCK SALE

CLUE TO AIDS VACCINE EFFECTIVENESS

SYNERGEN TO SPLIT STOCK 3 FOR 2

NEW COMPANY TO FOCUS ON CELL RECEPTORS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...